Cryoablation Devices
Jul 30, 2026
SIO Urges NCCN to Add Cryoablation to Breast Cancer Guidelines Following ProSense® FDA Clearance; NIPRO CORPORATION Secures FDA 510(k) Clearance for ELISIO™-HX HDs in the US; Akido Unveils the First AI-Native Health System in the U.S.; MemorialCare Enhances Diagnostic Imaging with Hung Family-Funded 3T MRI Technology; Aqua Medical Treats First U.S. Type 2 Diabetes Patient at UNC Health with Investigational Endoscopic Therapy; NeoCast Delivers Robust Hematoma Resolution and Functional Recovery in Final EMBO-02 First-in-Human Results
ceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense® On 29 July 2026, the Society of Interventional Oncology (SIO) submitted a formal petition to the National Comprehensive Cancer Network (NCCN) seeking the inclusion of percut...
Read More...
Apr 22, 2026
8 Applications of Cryoablation Devices in Healthcare
Cryoablation, the use of extreme cold to destroy abnormal tissue, has rapidly evolved from a niche surgical technique into one of the most versatile minimally invasive tools in modern medicine. By precisely delivering temperatures as low as –40°C to –170°C through specialized probes, cryoablation devices destroy ta...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
